Phillip G. Billington Sells 3,897 Shares of HCA Healthcare, Inc. (NYSE:HCA) Stock

HCA Healthcare, Inc. (NYSE:HCA) SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

HCA Healthcare Stock Down 0.7 %

NYSE:HCA opened at $342.96 on Friday. HCA Healthcare, Inc. has a 1-year low of $238.82 and a 1-year high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The firm has a market capitalization of $86.87 billion, a P/E ratio of 15.40, a PEG ratio of 1.34 and a beta of 1.68. The company’s fifty day moving average price is $386.00 and its 200-day moving average price is $357.03.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.77%. HCA Healthcare’s payout ratio is 11.85%.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. TD Cowen reduced their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. UBS Group lifted their price objective on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. Truist Financial boosted their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Finally, Royal Bank of Canada upped their price objective on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Five equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of HCA. Bangor Savings Bank lifted its position in shares of HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 45 shares in the last quarter. MFA Wealth Advisors LLC purchased a new stake in HCA Healthcare during the 2nd quarter worth approximately $27,000. Unique Wealth Strategies LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter worth $28,000. GPS Wealth Strategies Group LLC grew its holdings in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.